Diabetes
Use ‘more precise’ CVD risk scores to target therapy intensity for people with diabetes
Composite CVD risk factor control for U.S. adults with type 2 diabetes remains poor, but clinicians can use newer risk scores to better assess patients and prevent CV events with targeted therapies, according to a speaker.
Novel therapies targeting bile acid-triggered pathways may benefit children with NASH
Medications that target bile acid-triggered pathways and combination therapies could be the key for treating nonalcoholic steatohepatitis for young people with obesity and type 2 diabetes, according to a speaker.
Obesity management, teplizumab guidance among updates in ADA 2024 Standards of Care
New guidance on obesity management and cardiovascular disease screening for people with diabetes are among the updates in the American Diabetes Association’s 2024 Standards of Care.
Blood pressure remains largest contributor to global CVD; mortality on the rise
Global CV mortality and the prevalence of important cardiometabolic risk factors increased through 2022, with high BP remaining the strongest contributor, according to the 2023 update to the Global Burden of Disease special report on CVD.
The complex relationship between endometriosis and medical trust
In June 2022, PBS debuted Below the Belt, a documentary executive produced by Hillary Rodham Clinton. This thought-provoking film introduced viewers to four remarkable women grappling with the debilitating effects of endometriosis.
Lower cellular respiration found in platelets of patients with CKD
Updated recommendations, panel sessions among highlights at 21st annual WCIRDC meeting
Presentations on the latest cardiometabolic research, panel discussions and updated practice recommendations are among this year’s highlights at the 21st World Congress on Insulin Resistance, Diabetes & Cardiovascular Disease.
Top in endocrinology: Discrimination in drug trials; quality of life in transgender youth
Five obesity advocacy groups are calling on the FDA to require drug trials to include people with obesity and to update labels for drugs that may affect people with obesity differently.
How PCPs can address the 'undeniably significant' impact of ultraprocessed foods
Ultraprocessed foods are associated with poor health outcomes, but helping patients reduce their intake can be difficult because of their prevalence, broad definition and affordability, according to experts.
Stillbirth associated with increased severe maternal morbidity risk 1 year postpartum
Stillbirth was associated with an increased risk for severe maternal morbidity during delivery hospitalization and up to 1 year postpartum, researchers reported in the American Journal of Obstetrics & Gynecology.